Form 8-K - Current report:
SEC Accession No. 0001493152-26-024760
Filing Date
2026-05-21
Accepted
2026-05-21 11:31:14
Documents
18
Period of Report
2026-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 53370
2 EX-4.1 ex4-1.htm EX-4.1 139116
3 EX-4.2 ex4-2.htm EX-4.2 138449
4 EX-5.1 ex5-1.htm EX-5.1 11901
5 EX-10.1 ex10-1.htm EX-10.1 283095
6 EX-10.2 ex10-2.htm EX-10.2 113990
7 GRAPHIC ex5-1_001.jpg GRAPHIC 27959
8 GRAPHIC ex5-1_002.jpg GRAPHIC 10539
  Complete submission text file 0001493152-26-024760.txt   1115236

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE aim-20260520.xsd EX-101.SCH 3014
10 XBRL LABEL FILE aim-20260520_lab.xml EX-101.LAB 34239
11 XBRL PRESENTATION FILE aim-20260520_pre.xml EX-101.PRE 22359
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3094
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 261006619
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)